Is there a redundancy of β3 and other platelet receptors in the brain and central nervous system?

References

• Pletscher A. Platelets as models for monoaminergic neurons. Essays Neurochem Neuropharmacol 1978; 3: 49–101
   PubMedGoogle Scholar
• Nurden AT, Nurden P, Sanchez M, Andia I, Anitua E. Platelets and wound healing. Front Biosci 2008; 13: 3632–3646
   Google Scholar
• Hohmann S, Schweinfurth N, Lau T, Deuschle M, Lederbogen E, Banaschewski T. Differential expression of neuronal dopamine and serotonin transporters DAT and SERT in megakaryocytes and platelets generated from human MEG-01 megakaryoblasts. Cell Tissue Res 2011; 346: 151–161
   PubMed Web of Science ®Google Scholar
• Rowley JW, Oler AJ, Tolley ND, Hunter BN, Low EN, Nix DA, Yost GC, Zimmerman GA, Weyrich AS. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood 2011; 118: e101–e111
   PubMed Web of Science ®Google Scholar
• Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramrakrishnan V, Yang RB, Nurden P, Nurden A, Julius D, et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 2001; 409: 202–207
   PubMed Web of Science ®Google Scholar
• Haynes SE, Hollopeter G, Yang G, Kurpius D, Dailey ME, Gan WB, Julius D. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci 2006; 9: 1512–1519
   PubMed Web of Science ®Google Scholar
• Cattaneo M. The platelet P2Y12 receptor for adenosine disphosphate: Congenital and drug-induced defects. Blood 2011; 117: 2102–2112
   PubMed Web of Science ®Google Scholar
• Coller BS, Shattil SJ. The GPIIb/IIIa (intgerin αIIbβ3) odyssey: A technology-driven saga of a receptor with twists, turns and even a bend. Blood 2008; 112: 3011–3025
   PubMed Web of Science ®Google Scholar
• Napolioni V, Lombardi F, Sacco R, Curatolo P, Manzi B, Alessandrelli R, Militerni R, Bravaccio C, Lenti C, Saccani M, et al. Family-based association study of ITGB3 in autism spectrum disorder and its endophenotypes. Eur J Hum Genet 2011; 19: 353–359
   PubMedGoogle Scholar
• Weiss LA, Ober C, Cook Jr EH. ITGB3 shows genetic and expression interaction with SLC6A4. Hum Genet 2006; 120: 93–100
   PubMedGoogle Scholar
• Ma DQ, Rabionet R, Konidari I, Jaworski J, Cuckler HN, Wright HH, Abramson RK, Gilbert JR, Cuccaro ML, Pericak-Vance MA, et al. Association and gene–gene interaction of SLC6A4 and ITGB3 in autism. Am J Med Genet B Neuropsychiatr Genet 2010; 163B: 477–483
   Google Scholar
• Ruizzi L, Ciarafoni I, Silvestri L, Serrieraro ML, Abeni D. Association of PLA2 polymorphism of the ITGB3 gene with early fetal loss. Fertil Steril 2005; 83: 511–512
   PubMedGoogle Scholar
• Careiro AM, Cook EH, Murphy DL, Blakely RD. Interactions between integrin αIIbβ3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. J Clin Invest 2008; 118: 1544–1552
   PubMedGoogle Scholar
• Carter MD, Shah CR, Muller CL, Crawley JN, Carneiro AM, Veenstra-VanderWeele J. Absence of preference for social novelty and increased grooming in integrin β3 knock-out mice: Initial studies and future directions. Autism Res 2011; 4: 57–67
   PubMedGoogle Scholar
• Morrell CN, Sun H, Ikeda M, Beique J-C, Swaim AM, Mason E, Martin TV, Thompson LE, Gozen O, Ampagoomian D, et al. Glutamate mediates platelet activation through the AMPA receptor. J Exp Med 2008; 205: 575–584
   PubMed Web of Science ®Google Scholar
• Chavis P, Westbrook B. Integrins mediate functional pre- and postsynaptic maturation at a hippocampal synapse. Nature 2001; 411: 317–321
   PubMedGoogle Scholar
• Cingolani LA, Goda Y. Differential involvement of β3 integrin in pre- and postsynaptic forms of adaptation to chronic activity deprivation. Neuron Glia Biol 2008; 4: 179–187
   PubMedGoogle Scholar
• Pozo K, Cingolani LA, Bassani S, Laurent F, Passafaro M, Goda Y. β3 integrin interacts directly with GluA2 AMPA receptor subunit and regulates AMPA receptor expression in hippocampal neurons. Proc Natl Acad Sci USA 2012; 109: 1323–1328
   PubMedGoogle Scholar
• George JN, Caen JP, Nurden AT. Glanzmann's thrombasthenia: The spectrum of clinical disease. Blood 1990; 75: 1383–1396
   PubMed Web of Science ®Google Scholar
• Nurden AT, Fiore M, Nurden P, Pillois X. Glanzmann thrombasthenia: A review of ITGA2B and ITGB3 gene defects with emphasis on variants, phenotypic variability, and mouse models. Blood 2011; 118: 5996–6005
   PubMed Web of Science ®Google Scholar
• Coller BS, Cheresh DA, Asch E, Seligsohn U. Platelet vitronectin receptor expression differentiates Iraqi–Jewish from Arab patients with Glanzmann thrombasthenia in Israel. Blood 1991; 77: 75–83
   PubMed Web of Science ®Google Scholar
• Roux DT, Roullot V, Poujol C, Kortulewski T, Nurden P, Marguerie G. Thrombasthenic mice generated by replacement of the integrin αIIb gene: Demonstration that transcriptional activation of this megakaryocytic locus precedes lineage commitment. Blood 2000; 96: 1399–1408
   PubMedGoogle Scholar
• Hodilvala-Dilke KM, McHugh KP, Tsakaris DA, Raybum H, Crowley D, Ullman-Culleré M, Ross FP, Coller BS, Teitelbaum S, Hynes RO. Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest 1999; 103: 229–238
   PubMedGoogle Scholar
• Patel D, Vaananen H, Jirouskova M, Hoffmann T, Bodian C, Coller BS. Dynamics of GPIIb/IIIa-mediated platelet–platelet interactions in platelet adhesion/thrombus formation on collagen in vitro as revealed by videomicroscopy. Blood 2003; 101: 929–936
   PubMed Web of Science ®Google Scholar
• McHugh KP, Hodivala-Dilke K, Zheng M-H, Namba N, Lam J, Novack D, Feng X, Ross FP, Hynes RO, Teitelbaum SL. Mice lacking β3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest 2000; 105: 433–440
   PubMed Web of Science ®Google Scholar
• Weng S, Zemany L, Standley KN, Novack DV, La Regina M, Bernal-Mizrachi C, Coleman T, Semenkovitch CF. β3 integrin deficiency promotes atherosclerosis and pulmonary inflammation in high-fat-fed hyperlipidemic mice. Proc Natl Acad Sci USA 2003; 100: 6730–6735
   PubMedGoogle Scholar
• Reynolds LF, Conti FJ, Lucas M, Grose R, Robinson S, Stone M, Saunders G, Dickson S, Hynes RO, Lacy-Hulbert A, et al. Accelerated re-epithelialization in β3-integrin-deficient-mice is associated with enhanced TGF-β1 signaling. Nat Med 2005; 11: 167–174
   PubMed Web of Science ®Google Scholar
• Reynolds AR, Reynolds LE, Nagel TE, Lively JC, Robinson SD, Hicklin DJ, Bodary SC, Hodivala-Dilke KM. Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in β3-integrin-deficient mice. Cancer Res 2004; 64: 8643–8650
   PubMed Web of Science ®Google Scholar
• Desgrosellier JS, Cheresh DA. Integrins in cancer: Biological implications and therapeutic opportunities. Nat Rev Cancer 2010; 10: 9–22
   PubMed Web of Science ®Google Scholar